CCP Virus Patients Rush to Join Studies of Gilead Drug

CCP Virus Patients Rush to Join Studies of Gilead Drug
A vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in March 2020. Gilead Sciences via AP
|Updated:

The new CCP virus made Dr. Jag Singh a patient at his own hospital. His alarm grew as he saw an X-ray of his pneumonia-choked lungs and colleagues asked his wishes about life support while wheeling him into Massachusetts General’s intensive care unit.

When they offered him a chance to help test remdesivir, an experimental drug that’s shown promise against some other CCP (Chinese Communist Party) viruses, “it did not even cross my mind once to say ‘no,’” said Singh, a heart specialist.